Intramuscular Vitamin B12 Therapy Dosing
For vitamin B12 deficiency with neurological involvement, administer hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs, then continue with 1 mg every 2 months; for deficiency without neurological involvement, give hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by lifelong maintenance of 1 mg every 2-3 months. 1
Critical First Step: Assess for Neurological Involvement
Before initiating therapy, determine whether neurological symptoms are present. This distinction fundamentally changes your treatment approach:
Neurological symptoms to assess:
- Unexplained sensory disturbances
- Motor dysfunction
- Gait abnormalities
- Cognitive changes
If any neurological involvement is suspected, seek urgent specialist advice from both a neurologist and haematologist before starting treatment 1.
Treatment Protocols
With Neurological Involvement (Intensive Protocol)
Loading phase:
- Hydroxocobalamin 1 mg IM on alternate days
- Continue until no further clinical improvement observed
- This may require weeks to months of treatment
Maintenance phase:
- Hydroxocobalamin 1 mg IM every 2 months lifelong 1
Without Neurological Involvement (Standard Protocol)
Loading phase:
- Hydroxocobalamin 1 mg IM three times per week for 2 weeks
- Total of 6 injections over the initial treatment period
Maintenance phase:
- Hydroxocobalamin 1 mg IM every 2-3 months lifelong 1
Important Clinical Considerations
Formulation Specifics
The FDA-approved cyanocobalamin formulation is available as 1,000 mcg/mL for IM or subcutaneous use 2. While the guidelines reference hydroxocobalamin (the preferred form in UK practice), cyanocobalamin 1,000 mcg can be used with equivalent dosing schedules in the United States 3, 4.
Critical Safety Warning
Never administer folic acid before treating B12 deficiency. Folic acid supplementation can mask underlying vitamin B12 deficiency and precipitate subacute combined degeneration of the spinal cord—a devastating and potentially irreversible neurological complication 1.
Response Monitoring
Biochemical responses occur rapidly—within 1 day of intramuscular administration, you'll see increases in serum B12 and decreases in homocysteine and methylmalonic acid 5. However, hematological parameters like mean cell volume may take 14 days to normalize 5.
Individual Variation in Maintenance Requirements
While guidelines recommend every 2-3 months for maintenance, clinical experience suggests up to 50% of patients require more frequent dosing (ranging from every 2-4 weeks) to remain symptom-free 6. Do not titrate injection frequency based on serum B12 or MMA levels—instead, base adjustments on clinical symptom resolution and patient quality of life 6.
Special Populations
For patients undergoing bariatric surgery or with malabsorptive procedures, the same protocols apply, with lifelong maintenance therapy being essential 1, 3.
Alternative Routes (Context-Dependent)
While oral high-dose B12 (1,000 mcg daily) can be effective in some malabsorption cases 7, 8, parenteral therapy remains the gold standard and preferred route when malabsorption is the underlying cause, particularly in pernicious anemia and post-surgical states 3, 6. The guidelines prioritize IM administration to ensure reliable absorption and therapeutic response.